featured-image

Accelerate Diagnostics, Inc. ( NASDAQ: AXDX ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Laura Pierson - Investor Relations Officer Jack Phillips - Chief Executive Officer, President & Director David Patience - Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Dustin Scaringe - William Blair Operator Good day, and welcome to the Accelerate Diagnostics Incorporated. First Quarter 2024 Results Conference Call.

All participants will be in a listen only mode. After today's presentation there will be an opportunity to ask questions with our covering analysts. I would now like to turn the conference over to Ms.



Laura Pierson of Accelerate Diagnostics. Please go ahead ma'am. Laura Pierson Before we begin, it is important to share that information presented during this call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

Forward-looking statements include projections, statements about our future and those that are not historical facts. All forward-looking statements are made during this conference call are subject to risks, uncertainties and other factors that could cause our actual results to differ materially. These are discussed in greater detail in our annual report on Form 10-K for the year ended December 31, 2023 and other reports we file with the SEC.

It is my pleasure to .

Back to Beauty Page